The outlook on the prevention, diagnosis and treatment of Alzheimer’s disease is brighter than ever. Backed by decades of ...

I’ve seen firsthand how devastating Alzheimer’s can be — not just for the individuals living with it but also for their loved ...

“The NIH decision to restrict access to key genomic and medical datasets hinders global cooperation at a time when coordinated action is needed”, said Anjee Davis (Fight Colorectal Cancer, Springfield ...

UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with ...

SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function.

When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer’s studies were swept ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids.

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

In a new study, light exercise was as good as higher-intensity workouts at preventing brain changes that can lead to dementia ...

People with dementia can get care at home from family or appointed caretakers. Learn how dementia home care helps patients ...